Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation  by Sheng, Xia et al.
Journal of the American College of Cardiology Vol. 57, No. 5, 2011
© 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00Prevention and Reversal of Atrial Fibrillation
Inducibility and Autonomic Remodeling by
Low-Level Vagosympathetic Nerve Stimulation
Xia Sheng, MD,* Benjamin J. Scherlag, PHD,† Lilei Yu, MD,† Shuyan Li, MD,† Reza Ali, MD,†
Ying Zhang, MD, PHD,‡ Guosheng Fu, MD, PHD,* Hiroshi Nakagawa, MD, PHD,†
Warren M. Jackman, MD,† Ralph Lazzara, MD,† Sunny S. Po, MD, PHD†
Hangzhou, China; and Oklahoma City, Oklahoma
Objectives We hypothesized that autonomic atrial remodeling can be reversed by low-level (LL) vagosympathetic nerve
stimulation (VNS).
Background Previously, we showed that VNS can be antiarrhythmogenic.
Methods Thirty-three dogs were subjected to electrical stimulation (20 Hz) applied to both vagosympathetic trunks at volt-
ages 10% to 50% below the threshold that slowed sinus rate or AV conduction. Group 1 (n  7): Programmed
stimulation (PS) was performed at baseline and during 6-h rapid atrial pacing (RAP). PS allowed determination
of effective refractory period (ERP) and AF inducibility measured by window of vulnerability (WOV). LL-VNS was
continuously applied from the 4th to 6th hours. Group 2 (n  4): After baseline ERP and WOV determinations,
6-h concomitant RAPLL-VNS was applied. Sustained AF was induced by injecting acetylcholine (ACh) 10 mM
into the anterior right ganglionated plexus (Group 3, n  10) or applying ACh 10 mM to right atrial appendage
(Group 4, n  9).
Results Group 1: The ERP progressively shortened and the WOV (sum of WOV from all tested sites) progressively in-
creased (p  0.05) during 3-h RAP then returned toward baseline during 3-h RAPLL-VNS (p  0.05). Group 2:
6-h concomitant RAPLL-VNS did not induce any significant change in ERP and WOV. Group 3 and Group 4: AF
duration (AF-D) and cycle length (AF-CL) were markedly altered by 3-h LL-VNS (Group 3: baseline: AF-D  389 
90 s, AF-CL  45.1  7.8 ms; LL-VNS: AF-D  50  15 s, AF-CL  82.0  13.7 ms [both p  0.001]; Group 4:
baseline: AF-D  505  162 s, AF-CL  48.8  6.6 ms; LL-VNS: AF-D  71  21 s, AF-CL  101.3  20.9 ms
[both p  0.001]).
Conclusions LL-VNS can prevent and reverse atrial remodeling induced by RAP as well as suppress AF induced by strong cholin-
ergic stimulation. Inhibition of the intrinsic cardiac autonomic nervous system by LL-VNS may be responsible for these
salutary results. (J Am Coll Cardiol 2011;57:563–71) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.09.034o
a
lThe pathological consequence of atrial fibrillation (AF)
known as atrial remodeling takes the form of electrical,
contractile, and ultrastructural changes (1–7). Atrial re-
modeling has been shown in both animal (1– 4) and
human hearts (5–7). Conversion to maintained sinus
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2010, accepted September 2, 2010.rhythm can reverse these changes, but the longer the
duration of AF, the less effective such a reversal becomes.
Early conversion of the paroxysmal form of AF, there-
fore, should prevent the progression of AF to a persistent
and long-standing form associated with additional abnor-
malities caused by remodeling and thereby less chance of
restoring the rhythm to normal.
In a recent report from our laboratory (8), we demonstrated
that rapid atrial pacing (RAP) up to 6 h was associated with a
significant increase in AF inducibility, an acute form of “AF
begets AF” originally proposed by Wijffels et al. (1). This type
f atrial remodeling resulting from RAP was reversed by
blation of the 4 major left atrial ganglionated plexi and
igament of Marshall, suggesting the important role of the
hanges in the intrinsic cardiac autonomic nerve system (au-
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ing and perpetuating AF. In the
present report, we describe a non-
pharmacologic, nonablative meth-
odology to reverse and prevent
acute autonomic remodeling as
well as to suppress AF induced by
strong cholinergic stimulation.
Methods
Animal preparation. All animal
studies were reviewed and ap-
proved by the Institutional Ani-
mal Care and Use Committee of
the University of Oklahoma
Health Sciences Center. Thirty-
three adult mongrel dogs (20 to
30 kg) were anesthetized with
Na-pentobarbital, 50 mg/kg, and
ventilated with room air by a
positive pressure respirator. Core
body temperature was maintained
at 36.5 1.5°C. Standard electro-
cardiogram leads and blood pres-
sure were continuously recorded.
The procedures, including an-
imal preparations, bilateral tho-
racotomy, and position of multi-
electrode catheters at several
atrial and pulmonary vein (PV)
sites have been communicated in
detail elsewhere (8) (Fig. 1). All
recordings were displayed on a
computerized, electrophysiology
system (Bard Inc., Billerica,
Massachusetts). Electrocardio-
gram recordings were made with filter settings of 0.1 to 250
Hz, whereas electrogram recordings were filtered between
30 and 250 Hz.
Programmed stimulation. Left atrial appendage was
paced at 1,200 beats/min (2 threshold) to induce acute
atrial remodeling. After each hour of pacing, RAP was
temporarily stopped for 5 to 10 min to measure the effective
refractory period (ERP) and AF inducibility. ERP at atrial
or PV sites was determined by programmed stimulation that
consisted of 8 consecutive stimuli (S1-S1  330 ms)
followed by a premature stimulus (S1-S2). The S1-S2
intervals were decreased from 150 ms initially by decrements
of 10 ms and then 1 ms when approaching ERP (8). Pacing
was performed at 10 threshold. ERP dispersion was
calculated offline as the coefficient of variation (mean SD)
of the ERP at all 8 recording sites (8). AF was defined as
irregular atrial rates 500 beats/min and a duration 5 s,
associated with irregular atrioventricular conduction. The
Abbreviations
and Acronyms
AF  atrial fibrillation
AF-CL  atrial fibrillation
cycle length
AF-D  atrial fibrillation
duration
ANS  autonomic nervous
system
ARGP  anterior right
ganglionated plexus
ERP  effective refractory
period
HFS  high-frequency
stimulation
LAA  left atrial
appendage
LA  left atrium
LL-VNS  low-level
vagosympathetic nerve
stimulation
LSPV  left superior
pulmonary vein
PV  pulmonary vein
RA  right atrium
RAA  right atrial
appendage
RAP  rapid atrial pacing
RIPV  right inferior
pulmonary vein
RSPV  right superior
pulmonary vein
WOV  sum of the
window of vulnerability at
all recording sitesdifference between the longest and shortest S1-S2 interval(in ms) at which AF was induced was defined as the window
of vulnerability (WOV). The WOV served as a quantitative
measurement of AF inducibility. The WOV was the sum
of WOVs at all sites in each dog (8).
Low-level vagosympathetic nerve stimulation. A pair of
Teflon-coated silver wires (0.1-mm diameter) was inserted
into the cervical vagosympathetic trunks after dissection.
Vagosympathetic nerve stimulation (VNS) was performed
by applying high-frequency electrical stimulation (HFS) (20
Hz, 0.1 ms duration, square waves) to both vagosympathetic
trunks via a Grass stimulator (AstroMed, West Warwick,
Rhode Island). The lowest voltage level of VNS that
induced any slowing of the sinus rate or AV conduction
(measured by the A-H interval) was considered the threshold.
A voltage 10% or 50% lower than the threshold was then
chosen as the voltage for low-level (LL) VNS. Prior to each
hour of LL-VNS, the threshold of VNS was determined again
in order to adjust the voltage for LL-VNS for the next hour.
During LL-VNS, sinus rate and A-H interval were monitored
to ensure that the stimulation voltage was below the threshold.
Experimental protocol 1: 6-h RAP. GROUP 1 (N  7). At
he end of each hour of the 6-h RAP, programmed stimulation
s described in the previous text was performed to determine
he ERP and WOV at all sites during sinus rhythm. Bilateral
L-VNS 10% below threshold was applied during the last 3 h
f the 6-h RAP.
GROUP 2 (N  4). After determinations of the baseline values
f ERP and WOV, RAP and concomitant LL-VNS were
pplied for 6 h with hourly determinations of the ERP and
WOV as described above.
In 3 other animals, LL-VNS was delivered for 3 h
ithout RAP to serve as controls.
xperimental protocol 2: AF induced by injecting acetyl-
holine into the anterior right ganglionated plexus. GROUP
(N  10). To induce sustained AF, 10 mM acetylcholine
Ach) (0.5 ml) was injected into the fat pad containing the
nterior right ganglionated plexus (ARGP) as previously
escribed (9). Continuous monitoring was used to detect
hanges in heart rate, occurrence of premature depolariza-
ions, initiation of AF, and duration of atrial tachyarrhyth-
ias after ACh injection. If spontaneously AF did not occur
n 5 min, AF was induced by delivering an atrial premature
eat. The average AF cycle length was determined at the
ight superior PV (RSPV) site adjacent to the injected
RGP by measuring the average interval encompassing the
rst 20 electrograms after the onset of AF. After 3 h of
L-VNS (50% below threshold) applied during sinus
hythm, 10 mM ACh was injected into the ARGP again,
nd all the measurements described above were repeated. In
/10 animals, we injected 10 mM ACh into the ARGP in
he baseline and without 3-h LL-VNS, to serve as controls.
xperimental protocol 3: sustained AF induced by ap-
lying ACh-moistened gauze pad to right atrial append-
ge. GROUP 4 (N  9). In this group, sustained AF wasinduced by placing an ACh-moistened (10 mM, 0.5 ml)
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February 1, 2011:563–71 Low-Level Vagal Stimulationgauze pad (area  240 mm2) on the right atrial appendage
(RAA) in the baseline state and at the end of each hour of
the 3-h LL-VNS (50% below threshold) (10). A plastic
barrier was sutured to the base of RAA and sealed with
tissue glue to prevent ACh from leaking into the rest of the
atrium (10). The changes of heart rate, premature depolar-
ization, AF duration, and cycle length were determined as
described above. In 3 of 9 animals, an ACh-moistened
gauze pad was applied to the RAA at the baseline and the
end of each hour for 3 h without LL-VNS to serve as
controls.
Statistical analysis. Data were expressed as mean  SD.
Paired t tests were used for comparisons of ERP and WOV
at the end of each hour versus ERP and WOV: 1) in the
baseline state (asterisks, Figs. 2 to 4); or 2) at the end of the
3rd hour of RAP where the largest changes in ERP and WOV
were observed (triangles, Figs. 2 to 4). No adjustments for
multiple comparisons were made for these tests. In Group 3
and Group 4, ANOVA for repeated measures was used to
compare the changes before and after ACh intervention.
Values of p  0.05 were considered statistically significant.
Results
Throughout the experiment, blood pressure was stable and
no evidence of heart failure was found as a result of rapid
atrial pacing. There was no significant change in the VNS
threshold, indicating that the vagosympathetic trunks were
not damaged during the entire period of the experiment
(Table 1). In the 3 control animals that received LL-VNS
for 3 h without preceding or concomitant RAP, WOV
(1.3  1.1 ms, baseline; 0.7  0.6 ms, 3-h, p  0.05) and
Figure 1 Schematic Representation of the Right and Left Thora
(A) Right thoracotomy. Multielectrode catheters were sutured to the epicardial sur
superior (RSPV) and right inferior (RIPV) pulmonary veins (PVs). For Group 4 experi
(B) Left thoracotomy. Similarly, multielectrode catheters were positioned at the le
(LAA). Rapid atrial pacing (1,200 beats/min) was applied at the LAA. IVC  inferioERP did not change significantly (baseline: RSPV  94  h17 ms; right inferior PV [RIPV] 99 11 ms; left superior
PV [LSPV] 90 10 ms; left inferior PV [LIPV] 89  4
ms; right atrium [RA]  96  4 ms; left atrium [LA] 
96 5 ms; left atrial appendage [LAA] 94 14 ms; after
3-h LL-VNS: RSPV  98  12 ms; RIPV  100  14 ms;
LSPV 93 9 ms; LIPV 92 8 ms; RA 94 7 ms;
A  97  5 ms; LAA  92  13 ms; p  0.05 for all).
RP changes. In Group 1, as a result of RAP, ERP at all
ecording sites were significantly shortened in the first or the
econd hour (Fig. 2). After the initiation of LL-VNS (10%
elow threshold), ERP shortening at all sites was reversed,
nd returned to the baseline values at the end of the 6th
our. For example, ERP at the LSPV site was shortened
rom 99.2 12.7 ms in the baseline state to 89.2 10.1 ms
t the end of 1st hour, and reached 78.0  10.9 ms at the
nd of the 3rd hour (p  0.05 for all). LL-VNS reversed
hese changes (91.2  14.0 ms, and 97.3  6.7 ms at the
nd of the 5th and 6th hour, respectively; p 0.05 for both,
ompared to the end of 3-h RAP). For Group 2 animals, no
ignificant ERP shortening was detected at all recording
ites when RAP and LL-VNS (10% below threshold) were
pplied simultaneously (Fig. 3).
OV changes. When AF was induced by programmed
timulation, AF typically lasted for 30 s and terminated
pontaneously but was re-inducible by programmed stimu-
ation. The cumulative WOV (WOV) steadily increased
uring RAP in Group 1 (Fig. 4A). With RAP, the WOV
ncreased significantly to 59.3  25.2 ms at 2 h and 90.7 
2.7 ms at 3 h (p  0.001 for both, compared with
aseline). After the initiation of LL-VNS, the WOV
radually declined to 20.8  10.3 ms at the end of the 6th
my Approach and Catheter Positions in the Atria and PVs
f right atrial appendage (RAA), right atrial free wall (RA), and to the adjacent right
, a plastic barrier was used to isolate the RAA from the rest of the atrium.
rior PV (LSPV), left inferior PV (LIPV), left atrium (LA), and left atrial appendage
cava; LOM  ligament of Marshall; SVC  superior vena cava.coto
face o
ments
ft supe
r venaour (p  0.001, compared with the end of the 3rd hour of
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Low-Level Vagal Stimulation February 1, 2011:563–71RAP). No increase in the WOV was observed during the
entire experimental period when RAP and LL-VNS were
applied simultaneously (Fig. 4B).
ERP dispersion. In Group 1, there was a statistically
significant increase in the ERP dispersion in the first 3 h
(Fig. 4C). When LL-VNS was continuously applied
from the 4th to 6th hour, ERP dispersion regressed
toward the baseline values. In contrast, concomitant
RAPLL-VNS failed to increase the ERP dispersion
(Fig. 4D).
The differences in the changes of ERP, ERP dispersion
and WOV between group 1 and 2 at the end of 3-h RAP
Figure 2 Change of Mean ERP at Different Recording Sites Dur
p  0.05 and p  0.01 compared with baseline using paired t test; p  0.05, 
ing (RAP) using paired t test. ERP  effective refractory period; LL-VNS  low-level vagwere also found to be statistically significant (Fig. 5).AF duration and cycle length. GROUP 3. In the baseline
state, injection of ACh into the ARGP resulted in
spontaneous occurrence of AF in 4/10 dogs. In the other
6 dogs, AF was easily induced by delivering a premature
atrial depolarization. After 3 h of LL-VNS (50% below
threshold), spontaneous AF occurred in 2/4 of the
control dogs (without LL-VNS) but in none of the 6
dogs receiving LL-VNS. Figures 6A to 6D show a
marked decrease in the atrial fibrillation duration (AF-D)
and increase in the atrial fibrillation cycle length (AF-CL) after
3-h LL-VNS (baseline: AF-D 389 90 s, AF-CL 45.1
 7.8 ms; 3-h LL-VNS: AF-D 50 15 s, AF-CL 82.0
-h RAP Accompanied by LL-VNS in the Last 3 h (Group 1, n  7)
0.01, and p  0.001 compared with the end of the 3rd hour of rapid atrial pac-
athetic nerve stimulation; other abbreviations as in Figure 1.ing 6
p
osymp 13.7 ms [both p  0.0001]) but not in the control dogs
w
3
4
L
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February 1, 2011:563–71 Low-Level Vagal Stimulation(baseline: AF-D  486  150 s, AF-CL  37.1  7.6 ms,
ithout 3-h LL-VNS: AF-D  471  115 s, AF-CL 
5.6  5.9 ms, p  0.05 for both).
GROUP 4. In the baseline state and at the end of each hour
of LL-VNS (50% below threshold), sustained AF was
induced by placing an ACh-moistened gauze pad on the
RAA. Figures 6E to 6H show that the AF-D was substan-
tially decreased and AF-CL was greatly increased by just
1-h LL-VNS (baseline: AF-D  505  162 s, AF-CL 
8.8  6.6 ms; 1-h LL-VNS: AF-D  133  54 s [p 
0.01], AF-CL  71.0  16.4 ms [p  0.0001]; 2-h
L-VNS: AF-D  79  31 s [p  0.01], AF-CL  85.3
 4.4 ms [p  0.0001]; 3-h LL-VNS: AF-D  71  21 s
[p  0.0001], AF-CL  101.3  10.9 ms. In contrast, the
Figure 3 Change in Mean ERP at Different Recording Sites Dur
When RAP and LL-VNS were applied concomitantly, the ERP was not altered througsham LL-VNS did not induce any change in AF-D orAF-CL (baseline: AF-D 455 152 s, AF-CL 44.8
6.0 ms; 3-h LL-VNS: AF-D  495  124 s, AF-CL 
45.3  12.1 ms (p  0.05 for all).
For Group 3 and 4 animals, the differences in the changes
of AF-D and AF-CL between LL-VNS and no LL-VNS
were also found to be statistically significant (Fig. 7).
Discussion
Main finding. Since the last century, VNS had been used
to induce and maintain AF (11). In the present study, we
observed a paradoxical antiarrhythmic effect of LL-VNS to
substantially suppress AF in 3 acute animal models. Acutely,
RAP induced shortening of ERP, an increase in AF
inducibility, and an increase in ERP dispersion. LL-VNS
-h RAP and Concomitant 6-h LL-VNS (Group 2, n  4)
he 6-h period. Abbreviations as in Figures 1 and 2.ing 6
hout treversed these changes. When 6-h RAP was delivered in the
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Low-Level Vagal Stimulation February 1, 2011:563–71presence of LL-VNS, the aforementioned electrophysiolog-
ical properties were not altered. Our results indicate that the
acute electrical remodeling described as part of “AF begets
AF” may be reversed and prevented by LL-VNS. In
addition, LL-VNS (50% below threshold) markedly short-
ened the duration and increased the cycle length of AF
induced by very strong cholinergic stimulation described in
Group 3 and 4 experiments. Particularly, the AF-D was
reduced by nearly 80% by only 1 h of LL-VNS that was 50%
below the threshold.
“AF begets AF” and cardiac autonomic nerve system. Wi-
jffels et al. (1,12) established an AF animal model by RAP
and introduced the concept of “AF begets AF” (atrial
remodeling). In the present study, the significant changes of
ERP, WOV, and ERP dispersion were detected in the first
3 h with RAP, consistent with the concept that electrophys-
iological changes lead to a more stable substrate to facilitate
the maintenance of AF (1,12). Over the past decade,
multiple mechanisms have been proposed to account for
Figure 4 Change of WOV and ERP Dispersion During 6-h RAP
Cumulative WOV (WOV) (A) and ERP dispersion (C) were increased by 3-h RAP b
were not altered if LL-VNS and RAP were applied concomitantly. All symbols for p
The Mean VNS Threshold (in Volts) That Slowed the Sinus Rate orTable 1 The Mean VNS Threshold (in Volts) That Slowed the S
Baseline 1st Hour 2nd Hour
Group 1 (n  7) 0.32 0.14
Group 2 (n  4) 0.38 0.15 0.39 0.14 0.40 0.08p  0.05 for all.
AV  atrioventricular; VNS  vagosympathetic nerve stimulation.atrial remodeling. Chronic RAP induced AF and caused
significant reduction of the transient outward K current
and L-type Ca current as well as cellular ultrastructure
and Ca2 handling abnormalities (13,14). Sustained AF
lso increased superoxide production in both LA and
AA, which may contribute to atrial remodeling (15).
trial fibrosis is another important factor. However,
ncreased fibrosis is unlikely a factor in our acute AF
odel but plays an important role in AF induced by
hronic RAP (16).
Another major contributing factor to atrial remodeling is
utonomic remodeling. Chronic RAP increases the inner-
ation of the atrial sympathetic nerve system (17). This
esult suggested that the remodeling of intrinsic cardiac
utonomic nervous system (ANS) may be involved in atrial
emodeling. A recent study from our institute further
ighlighted the critical role of the intrinsic cardiac ANS in
cute atrial remodeling. Inhibition of the intrinsic cardiac
NS by ablating the 4 major atrial ganglionated plexi and
e reversed by LL-VNS. In contrast, WOV (B) and ERP dispersion (D)
as in Figure 2. Abbreviations as in Figures 1 and 2.
onduction During the Entire Experimental Periodate or AV Conduction During the Entire Experimental Period
3rd Hour 4th Hour 5th Hour 6th Hour
0.34 0.11 0.37 0.13 0.38 0.07
0.36 0.08 0.38 0.06 0.427 0.12 0.40 0.08ut wer
valuesAV Cinus R
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February 1, 2011:563–71 Low-Level Vagal Stimulationligament of Marshall or by administering autonomic block-
ade (atropine or esmolol) before the initiation of 6-h RAP
prevented acute atrial remodeling, whereas acute atrial re-
odeling can be reversed if these interventions were initi-
ted within a few hours after RAP was started (8). That
tudy provides experimental evidence that autonomic
emodeling is an important element in the early phase of
trial remodeling and inspired us to design the present
tudy to seek an alternative approach to globally sup-
ressing the intrinsic cardiac ANS and in turn prevent
he progression of AF.
xplanations for suppression of AF by LL-VNS. The
esults of our study showed that LL-VNS had a potent
nhibitory effect on AF induced by strong cholinergic
Figure 5 Comparison Between Groups 1 and 2
p  0.01 and p  0.001. Abbreviations as in Figures 1 and 2.timulation as well as acute atrial remodeling induced byAP, regardless of whether LL-VNS was initiated before
r within a few hours of RAP. Prior studies have implied
hat interactions between the extrinsic and intrinsic cardiac
NS may have a significant impact on cardiac electrophys-
ology. First, by a combination of microinjection, dual
ntegrade tracing, and confocal microscopic technique to
xamine vagal efferent axons and terminals in cardiac
anglia, Ai et al. (18) observed that vagal efferent fibers
amified within cardiac ganglia. They formed a complex
etwork of axons, and innervated cardiac ganglia with very
ense basket endings around individual cardiac principal
eurons (18). These findings provide strong anatomical
vidence for explaining the complex interactions between
he extrinsic and intrinsic cardiac ANS. Second, not all
NS is arrhythmogenic. The strength and duration of VNS
ay dictate its effects. Zhang et al. (19) found that AF
nducibility by right cervical VNS was intensity dependent.
trong VNS (60% sinus rate slowing) facilitated AF
nducibility, whereas moderate VNS (slowing the sinus rate
Figure 6 Changes of AF Duration and Cycle Length
by 3-h LL-VNS
(A to D) Group 3. (E to H) Group 4. (p  0.05; p  0.01; p  0.0001).
See text for details. AF  atrial fibrillation; CL  cycle length; LL-VNS  low-
level vagosympathetic nerve stimulation.
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Low-Level Vagal Stimulation February 1, 2011:563–71by 10%) for 4 weeks did not affect AF inducibility, and
imposed no arrhythmogenic risk (19). Prior to a 7-h RAP,
Takei et al. (20) stimulated both vagus nerves, which slowed
the sinus rate by 30%. Surprisingly, ERP did not shorten
after 7 h of RAP (20). These observations implied that VNS
may be antiarrhythmic. Third, the intrinsic cardiac ANS
comprises the “integration center” for the co-ordination of
regional cardiac reflex, for which the intrinsic cardiac ANS
is considered the “little brain” of the heart (21). The
interactions between the extrinsic and intrinsic cardiac ANS
are complex and remain poorly understood. Zhang et al.
(22) studied the effect of bilateral VNS on tonic firing
recorded from the ARGP. Shortly after VNS application,
GP neural activity was completely suppressed, and demon-
strated that activation of the extrinsic cardiac ANS can
suppress the neural activity in the intrinsic cardiac ANS. In
a recent study from our group, AF threshold progressively
increased during a period of 3 h when LL-VNS (50% below
threshold) was applied only to the right vagosympathetic
trunk (23). The amplitude and frequency of the ARGP
neural activity were also markedly inhibited by LL-VNS of
the right vagosympathetic trunk. Taken together (22,23),
these results reinforce the notion that the extrinsic cardiac
ANS may suppress the activity of intrinsic cardiac ANS and
subsequently suppress AF.
It is known that vagosympathetic trunks carry mainly
afferent nerve fibers that project primarily or secondarily to
multiple areas in the brain, many of which are not known to be
excitatory or inhibitory. In a recent study, we transected both
vagosympathetic trunks in 6 dogs; LL-VNS was then applied
at the distal end of the nerve trunks (24). LL-VNS still
Figure 7 Comparison Between LL-VNS and No LL-VNS (Sham) A
p  0.01 and p  0.001, compared with baseline. ##p  0.01 and ###p induced similar changes in AF threshold at multiple atrial andPV sites as LL-VNS with intact vagosympathetic trunks,
indicating that the inhibitory effects of LL-VNS on cardiac
electrophysiology involve efferent activation to the heart.
Study limitations. We hypothesize that the mechanism
responsible for the atrial antifibrillatory effect of LL-VNS
may be due to inhibition of the intrinsic cardiac ANS by the
extrinsic cardiac ANS. This hypothesis is based on prior
studies (20 –24) and the electrophysiological evidence
shown in the present study. Although we have no direct
evidence indicating an inhibition of neuronal firing within
the GP, the accumulated indirect evidence supports the
inhibitory hypothesis. This hypothesis will have to be
verified in the future when the neural activity from the GP
of a beating heart can be reliably recorded over 6 to 8 hours.
Clinical implications. A therapeutic modality that can
prevent paroxysmal AF to progress to persistent forms may
greatly reduce the resultant mortality and morbidity associ-
ated with this arrhythmia. Notably, LL-VNS, which was
50% below threshold, was still capable of reducing the AF
duration by80%. The present study introduced a potential
therapy that is less invasive than catheter or surgical abla-
tion, and may limit the duration of or even prevent AF
thereby reducing the risk of thromboembolic events or
cardiomyopathy.
Conclusions
LL-VNS can prevent and reverse the electrophysiological
changes of atrial remodeling induced by 6-h RAP as well as
suppress AF induced by strong cholinergic stimulation.
Inhibition of the intrinsic cardiac ANS by LL-VNS may be
g Group 3 and 4 Animals
1, compared with no low-level vagosympathetic nerve stimulation (LL-VNS).mon
0.00responsible for these salutary results. LL-VNS may serve as
571JACC Vol. 57, No. 5, 2011 Sheng et al.
February 1, 2011:563–71 Low-Level Vagal Stimulationa novel therapeutic modality to treat AF related to acute
atrial remodeling or a hyperactive state of the intrinsic
cardiac ANS.
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